Scarica l'app Stockscreener
365.81
1.46%
-5.43
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché KRYS Giù?
Forum
Previsione
Precedente Chiudi:
$371.24
Aprire:
$375
Volume 24 ore:
363.52K
Relative Volume:
1.17
Capitalizzazione di mercato:
$10.78B
Reddito:
$417.30M
Utile/perdita netta:
$225.03M
Rapporto P/E:
48.90
EPS:
7.4815
Flusso di cassa netto:
$237.38M
1 W Prestazione:
-2.47%
1M Prestazione:
+17.09%
6M Prestazione:
+39.94%
1 anno Prestazione:
+144.30%
Intervallo 1D:
$355.55
$375.00
Intervallo di 1 settimana:
$355.55
$382.13
Portata 52W:
$130.50
$382.54
Krystal Biotech Inc Stock (KRYS) Company Profile
Nome
Krystal Biotech Inc
Settore
Industria
Telefono
(412) 586-5830
Indirizzo
2100 WHARTON STREET, PITTSBURGH, PA
Compare KRYS vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
KRYS
Krystal Biotech Inc
|
365.81 | 10.78B | 417.30M | 225.03M | 237.38M | 7.4815 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-27 | Iniziato | Wolfe Research | Peer Perform |
| 2026-01-06 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-03-05 | Iniziato | Jefferies | Buy |
| 2024-08-06 | Downgrade | Citigroup | Buy → Neutral |
| 2023-11-20 | Iniziato | Goldman | Buy |
| 2023-10-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-10-12 | Iniziato | Citigroup | Buy |
| 2023-09-07 | Iniziato | Berenberg | Buy |
| 2023-04-18 | Iniziato | Stifel | Buy |
| 2023-02-28 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-08-25 | Downgrade | Goldman | Buy → Neutral |
| 2022-01-18 | Iniziato | BofA Securities | Buy |
| 2021-07-20 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-09-18 | Iniziato | B. Riley FBR | Buy |
| 2020-06-04 | Iniziato | Evercore ISI | Outperform |
| 2019-09-24 | Iniziato | Goldman | Neutral |
| 2019-08-06 | Reiterato | H.C. Wainwright | Buy |
| 2019-06-24 | Reiterato | Chardan Capital Markets | Buy |
| 2019-06-24 | Reiterato | H.C. Wainwright | Buy |
| 2019-05-30 | Iniziato | Guggenheim | Buy |
| 2018-09-11 | Iniziato | Cantor Fitzgerald | Overweight |
Mostra tutto
Krystal Biotech Inc Borsa (KRYS) Ultime notizie
Is the options market predicting a spike in Krystal Biotech stock? - MSN
Here's why Krystal Biotech, Inc. (KRYS) is a strong momentum stock - MSN
(KRYS) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Analysts see more upside for Abivax, Krystal Biotech, Marvell - MSN
3 Soaring Stocks That May Have More Upside Ahead - The Globe and Mail
3 Soaring Stocks That May Have More Upside Ahead - The Motley Fool
Krystal Biotech focuses on gene-based dermatology treatments as investors watch long-term growth - ad-hoc-news.de
Krystal Biotech, Inc. (KRYS) Stock Analysis: A High-Potential Biotech with Robust Revenue Growth and Strategic Therapeutic Pipeline - DirectorsTalk Interviews
KRYSKrystal Biotech Inc Options - Finviz
Price to book forward of Krystal Biotech, Inc. – NASDAQ:KRYS - TradingView
Krystal Biotech Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
KRYS Stock Rallies On Upbeat Earnings: Jefferies Ups Price Target On Sustained Vyjuvek Optimism - Stocktwits
Krystal Biotech stock soars 16% in three months: Here's why - MSN
Krystal Biotech (KRYS) soars 3.4%: Is further upside left in the stock? - MSN
Krystal Biotech (KRYS) Soars 3.4%: Is Further Upside Left in the Stock? - Yahoo Finance
Krystal Biotech, Inc. (KRYS) Stock Analysis: A Biotech Marvel with 31.9% Revenue Growth and Strong Buy Ratings - DirectorsTalk Interviews
Krystal Biotech, Inc. Actuals & Estimates (FWB:4KB) - TradingView
Form 4 Krystal Biotech Inc For: 26 June By Investing.com - Investing.com South Africa
Krystal Biotech, Inc. Actuals & Estimates (MIL:1KRYS) - TradingView
Responsive Playbooks and the KRYS Inflection - Stock Traders Daily
Krystal Biotech EVP sells $347,270 in common stock - Investing.com UK
Krystal Biotech EVP sells $347,270 in common stock By Investing.com - Investing.com India
Krystal Biotech (KRYS) EVP executes 10b5-1 option exercise and 1,000-share sale - Stock Titan
Krystal Biotech Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus
High Growth Tech Stocks In US For June 2026 - simplywall.st
Krystal Biotech stock hits all-time high at 357.65 USD By Investing.com - Investing.com Australia
Krystal Biotech, Inc. Actuals & Estimates (MUN:4KB) - TradingView
Form 144 Krystal Biotech For: 25 June By Investing.com - Investing.com Australia
Krystal Biotech stock hits all-time high at 357.65 USD - Investing.com
KRYS (KRYS) option exercise: 1,000 shares to be sold on 06/25/2026 - Stock Titan
Krystal Biotech earnings outlook and chart levels, shares on Nasdaq watched by biotech investors - ad-hoc-news.de
Price to book forward of Krystal Biotech, Inc. – SWB:4KB - TradingView
KRYS Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to EBIT forward of Krystal Biotech, Inc. – NASDAQ:KRYS - TradingView
Enterprise value to revenue forward of Krystal Biotech, Inc. – NASDAQ:KRYS - TradingView
Price to sales forward of Krystal Biotech, Inc. – NASDAQ:KRYS - TradingView
Price to earnings forward of Krystal Biotech, Inc. – NASDAQ:KRYS - TradingView
The Brown Capital Management Small Company Fund Bets on Krystal Biotech (KRYS) for Its Resilient Revenue Stream - Insider Monkey
Krystal Biotech updates key Vyjuvek filing, shares trade firmly on Nasdaq - ad-hoc-news.de
Krystal Biotech (KRYS) Is Up 7.2% After Institutional Ownership Surges To Sector-Leading Levels - Sahm
Krystal Biotech, Inc. (KRYS) Stock Analysis: A $10.26 Billion Market Cap Player in Gene Therapy with Strong Buy Ratings - DirectorsTalk Interviews
3 Biotech Firms With Major Potential Catalysts in the Coming Months - MarketBeat
Krystal Biotech (KRYS) Climbs 1.87% as Shares Hold Above Established SupportGrowth ETF - dars.gov.et
Krystal Biotech Inc Azioni (KRYS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):